Cambridge-based CN Bio, an organ-on-a-chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems, has appointed Lydia Seymour as vice-president of people and culture.

Seymour has experience of HR and people management within the life science industry and has supported commercial, R&D, and corporate teams globally, particularly specialising in the US and APAC markets. She has held senior leadership positions at companies including Abcam, TTP Labtech, and Fluidigm Corporation. Most recently, she was vice-president of human resources at biotechnology company Evonetix.

CN Bio’s chief executive Dr Paul Brooks said: “We are extremely proud here at CN Bio to have built such a credible and professional team, who are helping to realise the full potential of organ-on-a-chip technology to revolutionise drug discovery and development. At such a pivotal time in CN Bio’s development, Lydia’s expertise in overseeing thorough strategies to ensure effective recruitment and training, as well as fostering inclusive and supportive company culture will be crucial as our team continues to expand globally and underscores our commitment to investing in people as the foundation of our business growth and innovation.”

Seymour said: “CN Bio’s innovative PhysioMimix OOC range of MPS hold great promise to transform how we approach drug discovery, enabling us to bring more effective therapies to market, faster. I look forward to harnessing my expertise in people management, working alongside Paul and the team to implement effective strategies that empower our talented team members to continue to innovate, and prepare the company for global expansion so that we can continue to meet the needs of our customers.”